Orchid Pharma Limited announced the appointment of Mr. Arjun Dhanuka as a Whole-Time Director during its Board Meeting on September 03, 2026. Mr. Dhanuka, previously a Non-Executive Non-Independent Director, brings extensive experience from the pharmaceutical sector, having worked with Dhanuka Laboratories and Synmedic Laboratories. His tenure is set for five years, concluding on September 02, 2031, signaling a key leadership development for the company.
Orchid Pharma Board Meeting Decisions
In a significant move for Orchid Pharma Limited, the Board of Directors convened on September 03, 2026, to discuss and approve several key agenda items. The meeting, which commenced at 18:00 P.M. IST and concluded at 19:45 P.M. IST, resulted in notable decisions concerning company leadership and regulatory compliance.
Appointment of Whole-Time Director
A primary resolution from the meeting was the appointment and recommendation of remuneration for Mr. Arjun Dhanuka (DIN: 00454689) as a Whole-Time Director. Mr. Dhanuka was formerly a Non-Executive Non-Independent Director. His appointment is effective from September 03, 2026, with a tenure extending up to September 02, 2031. Mr. Dhanuka’s professional background includes significant roles at Dhanuka Laboratories Limited and Synmedic Laboratories, where he gained over a decade of experience in pharmaceuticals, focusing on business development and strategy.
Cost Auditor Appointment and AGM Details
The Board also approved the appointment and remuneration of the company’s Cost Auditors for the Financial Year 2026-27. Further details regarding this appointment are provided in Annexure-I. Additionally, the company finalized the notice for its 33rd Annual General Meeting (AGM), scheduled to be held on September 29, 2026. The cut-off date for determining shareholder eligibility for receiving the AGM notice is set for Friday, September 04, 2026. The period for remote e-voting will commence on September 26, 2026, and conclude on September 28, 2026.
E-voting Agency and Scrutinizer Appointment
To facilitate the e-voting process for the upcoming AGM, the Board approved the appointment of an e-voting agency. Concurrently, a scrutinizer was appointed to oversee the e-voting process and submit the necessary report.
Source: BSE
